KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Treasury Shares (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Treasury Shares for 3 consecutive years, with $1.7 million as the latest value for Q3 2013.

  • Quarterly Treasury Shares changed 0.0% to $1.7 million in Q3 2013 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Sep 2013, changed 0.0% year-over-year, with the annual reading at $1.7 million for FY2012, 0.0% changed from the prior year.
  • Treasury Shares hit $16341.0 in Q3 2025 for ClearPoint Neuro, down from $23023.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.9 million in Q1 2021 to a low of $16341.0 in Q3 2025.
  • Historically, Treasury Shares has averaged $854583.9 across 5 years, with a median of $669157.0 in 2021.
  • Biggest YoY gain for Treasury Shares was 0.0% in 2012; the steepest drop was 0.0% in 2012.
  • Year by year, Treasury Shares stood at $1.7 million in 2011, then changed by 0.0% to $1.7 million in 2012, then changed by 0.0% to $1.7 million in 2013.
  • Business Quant data shows Treasury Shares for CLPT at $1.7 million in Q3 2013, $1.7 million in Q2 2013, and $1.7 million in Q1 2013.